HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

By STAT News · Jun 12, 2026 · via STAT News
STAT+: Up and down the ladder: The latest comings and goings

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
The Considered+AI is an AI-native agency that's been rooted in generative AI tools since its start in 2021.…
Jul 29, 2026
The WeekFierceBiotech ↗
Flush with GLP-1 cash and pipeline success, Eli Lilly rose from 16th to first over five years in Norstella's i…
Jul 29, 2026
Freenome gets FDA signoff, Abbott takes the U.S. commercialization role
The WeekBriefing
Freenome’s blood-based colorectal cancer test won FDA approval, and Abbott will exclusively market it in the U…
Jul 29, 2026